Monoclonal And Polyclonal Antibodies Research
44 researchers across 5 institutions
Antibody research explores the development, characterization, and application of monoclonal and polyclonal antibodies. Scientists investigate antibody production using various techniques, including hybridoma technology and recombinant DNA methods. This work addresses fundamental questions about immune system function, antibody-antigen interactions, and the development of diagnostic and therapeutic agents. Research spans areas such as identifying biomarkers for disease detection, developing targeted therapies for conditions like cancer and infectious diseases, and understanding immune responses to specific challenges. The precise engineering and validation of antibodies are central to advancing these fields.
In Arkansas, antibody research contributes to the state's growing biosciences sector and addresses significant public health needs. The development of new diagnostic tools and therapeutic strategies can improve patient outcomes for prevalent diseases within the state. Furthermore, understanding immune responses through antibody research can inform strategies for managing health challenges relevant to Arkansas's population, including those related to infectious diseases and chronic conditions. This work supports innovation in biotechnology and pharmaceutical development within the state.
This research area interfaces with numerous related fields, including molecular biology, immunology, pharmacology, and toxicology. Engagement across multiple Arkansas institutions fosters a collaborative environment for exploring antibody applications in areas such as cancer treatment, infectious disease research, and understanding the pharmacological effects and toxicity of various substances.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Roland Martinꝉ | UAMS | 100 | 42,705 | High Impact | |
| Frits van Rhee | UAMS | 82 | 25,962 | High Impact | |
| Stacie M. Jones | UAMS | 68 | 21,097 | High Impact | |
| Robert L. Jilka | UAMS | 57 | 16,446 | High Impact | |
| Henry K. Wong | UAMS | 41 | 6,029 | High Impact | |
| Donald M. Mock | UAMS | 41 | 5,479 | High Impact | |
| Donna L. Mendrick | NCTR | 40 | 9,001 | High Impact | |
| Carolina Schinke | UAMS | 36 | 4,915 | High Impact | |
| S. Michael Owens | UAMS | 36 | 3,466 | High Impact | |
| Andrew J. Pierce | Ouachita Baptist University | 34 | 7,520 | High Impact | |
| Sharmilan Thanendrarajan | UAMS | 31 | 3,516 | High Impact | |
| Noriko Nakamura | NCTR | 29 | 3,466 | High Impact | |
| W. Brooks Gentry | UAMS | 28 | 2,564 | High Impact | |
| Divaya Bhutani | UAMS | 25 | 2,670 | High Impact | |
| Behjatolah Monzavi‐Karbassi | UAMS | 24 | 1,603 | Grant PI High Impact | |
| Lu Dai | UAMS | 23 | 1,643 | ||
| Samer Al Hadidi | UAMS | 20 | 1,583 | ||
| Ahmmed Ally | University of Arkansas – Fort Smith | 17 | 803 | ||
| Melinda G. Gunnell | UAMS | 13 | 536 | ||
| Abdul Rafae | UAMS | 9 | 396 |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Monoclonal And Polyclonal Antibodies Research in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 National Institutes of Health 5,756
- 2 Harvard University 5,398
- 3 National Cancer Institute 3,785
- 4 Stanford University 3,263
- 5 Scripps Research Institute 2,682
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Monoclonal And Polyclonal Antibodies Research.